Marea Therapeutics
Latest round
- Series A
Last raised
- Jun 2024
Total raised
- Undisclosed
Investors
- 8
About Marea Therapeutics
Based in California, US, and co-founded by Charles Homcy, Stephen O’Rahilly, Joshua Rabinowitz, and Ethan Weiss (Chief Scientific Officer), Marea Therapeutics, Inc. operates as a biotechnology company that engages in the development of medicines for Cardiometabolic Diseases. In June 2024, Marea Therapeutics, Inc. The company combines human genetic insights with advanced adipocyte biology to target unmet medical needs in cardiovascular health. Marea Therapeutics' flagship product, MAR001, is a monoclonal antibody designed to inhibit ANGPTL4, a protein pivotal in adipose tissue function. This therapy aims to enhance lipoprotein lipase activity, thereby reducing remnant cholesterol levels and improving insulin sensitivity. The company's pipeline includes undisclosed programs targeting validated genetic markers, aiming to expand therapeutic options for metabolic dysfunction.
Who invested in Marea Therapeutics
8 investors across 2 rounds
See all investors in Marea Therapeutics
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about Marea Therapeutics
Who invested in Marea Therapeutics?
Marea Therapeutics has 8 investors on record across 2 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Marea Therapeutics raised?
Marea Therapeutics has raised 2 venture rounds. Sign up free to see how much each round raised and the total.
When did Marea Therapeutics last raise money?
Marea Therapeutics's most recent round on record is a Series A, in Jun 2024.
What does Marea Therapeutics do?
Based in California, US, and co-founded by Charles Homcy, Stephen O’Rahilly, Joshua Rabinowitz, and Ethan Weiss (Chief Scientific Officer), Marea Therapeutics, Inc.
Where is Marea Therapeutics headquartered?
Marea Therapeutics is headquartered in San Francisco, US.
Which VCs invest in companies like Marea Therapeutics?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back biotechnology companies at Marea Therapeutics's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series A
Raising like Marea Therapeutics? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.